#London #United Kingdom #Corundum Neuroscience #Corundum Systems Biology #SXSW London

The Future of Health at SXSW London

The inaugural SXSW London is set to be a landmark event, featuring a powerful collaboration between Corundum Neuroscience (CNS) and Corundum Systems Biology (CSB). Notably, two panel sessions will showcase innovative ideas on sleep technology and the human microbiome, taking place from June 2-7, 2025.

The Role of the Microbiome in Health

The first panel, titled "Can Microbiomes Deliver?", will occur on Tuesday, June 3, from 10:45 to 11:25 AM BST at the Truman Brewery. Under the moderation of Dr. Jessica Schneider, Chief Scientific Officer at CSB, experts including Dr. Hiroaki Kitano from the Okinawa Institute of Science and Technology, Dr. Colleen Acosta of Freya Biosciences, and Alice Ko from Joyance Partners will address the dynamic relationship between the human microbiome and personal health.

The microbiome, an intricate community of microorganisms within our bodies, is gaining recognition as a cornerstone of precision medicine. The panelists will explore its influential role in mediating health outcomes, reshaping our understanding of drug development, nutrition, and women’s health. Dr. Schneider emphasized the significance of moving towards personalized healthcare solutions, discussing how innovative microbiome research can pave the way for tailored medicine.

“Healthcare is transitioning from generalized approaches to individual solutions,” said Dr. Schneider, “and this panel gives us a chance to explore those transformative perspectives.”

Harnessing Sleep to Enhance Human Potential

The second session, "Dreaming Big: How Sleep Tech Unlocks Human Potential," will take place on Wednesday, June 4, from 1:30 to 2:10 PM BST, also at the Truman Brewery. Moderated by Dr. Ruthi Aladjem, Chief Product Strategist at CNS, this discussion will feature experts including Dr. Yuval Nir from Tel Aviv University, Dr. Caroline Lustenberger from ETH Zurich, and Simon Bachmann from Idun Technologies.

The panel aims to delve into the emerging field of sleep technology and its implications for understanding the brain's functions during sleep. The panelists will discuss recent breakthroughs that highlight sleep as a critical phase for cognitive health, early detection of neurodegenerative diseases, and overall human performance. Dr. Aladjem expressed excitement about the potential of sleep technology to improve mental wellness and redefine human capabilities in a rapidly evolving technological landscape.

“Sleep is more than just a restorative state; it’s a vital frontier in the quest for health innovation,” stated Dr. Aladjem, who believes this session will illuminate the profound impact sleep has on our performance and health.

About Corundum Neuroscience and Systems Biology

Founded by experienced executives from Joy Ventures, Corundum Neuroscience aims to propel transformative neuroscience solutions from concept to reality. Based in Herzliya, Israel, the organization supports researchers and entrepreneurs, fostering advancements targeting critical health challenges to improve quality of life.

On the other hand, Corundum Systems Biology is committed to promoting cutting-edge advancements in human health by investing in pioneering systems biology companies. Both organizations are at the forefront of integrating science and innovation to benefit individual and public health.

For more updates on their initiatives, follow Corundum Neuroscience and Corundum Systems Biology on LinkedIn or visit their respective websites.